 | Study programme 2024-2025 | Français | |
 | Faculty of Medicine, Pharmacy and Biomedical Sciences | ||
| Bachelor's in Pharmacy (MONS) (day schedule) |
- Panel Chairperson : Bertrand BLANKERT
- Panel Secretary : Stéphanie PATRIS
| Show AAs | |||||||||||||||||
| Bloc 1 | Hours (*) | Term | Credits | Weight. | |||||||||||||
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | ||||||||||||
| Enseignements obligatoires | |||||||||||||||||
 UM-B1-PHARMA-016-M Biologie générale humaine | 60 | 8 | 0 | 0 | 30 | 98 | Q1 | 8 | 8 | ||||||||
| UM-B1-PHARMA-011-M General Chemistry | 46 | 35 | 0 | 0 | 20 | 101 | Q1 | 6 | 6 | ||||||||
| UM-B1-PHARMA-012-M Organic Chemistry I | 20 | 19 | 0 | 0 | 20 | 59 | Q1 | 4 | 4 | ||||||||
| UM-B1-PHARMA-003-M Mathematical Introduction to Life Sciences | 24 | 24 | 0 | 0 | 30 | 78 | Q1 | 3 | 3 | ||||||||
| UM-B1-PHARMA-015-M Statistiques I | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-B1-PHARMA-020-M Physique biomédicale | 98 | 78 | 0 | 0 | 50 | 226 | Q1,Q2 | 13 | 13 | ||||||||
| UM-B1-PHARMA-013-M General Chemistry II | 30 | 28 | 0 | 0 | 0 | 58 | Q2 | 5 | 5 | ||||||||
| UM-B1-PHARMA-014-M Organic Chemistry II | 15 | 14 | 0 | 0 | 0 | 29 | Q2 | 3 | 3 | ||||||||
| UM-B1-PHARMA-005-M Mathematics in Life Sciences | 18 | 18 | 0 | 0 | 30 | 66 | Q2 | 3 | 3 | ||||||||
| UM-B1-PHARMA-021-M Biochimie générale | 20 | 10 | 0 | 0 | 3 | 33 | Q2 | 3 | 3 | ||||||||
| UM-B1-PHARMA-007-M Elements of Botany | 30 | 16 | 0 | 0 | 0 | 46 | Q2 | 4 | 4 | ||||||||
| UM-B1-PHARMA-009-M Introduction to Drug Treatments | 10 | 0 | 0 | 0 | 0 | 10 | Q2 | 2 | 2 | ||||||||
| UM-B1-PHARMA-010-M Introduction to Human Anatomy | 12 | 0 | 0 | 0 | 0 | 12 | Q2 | 2 | 2 | ||||||||
| UM-B1-PHARMA-018-M Initiation à la recherche en sciences pharmaceutiques | 0 | 32 | 0 | 0 | 0 | 32 | Q2 | 2 | 2 | ||||||||
| Enseignements transitoires 2024-2025 | 0 | ||||||||||||||||
| UM-B1-PHARMA-004-M Biomedical physics (UE transitoire) | 98 | 78 | 0 | 0 | 50 | 226 | Q1,Q2 | 14 | 14 | ||||||||
| UM-B1-PHARMA-017-M General Biochemistry (UE transitoire) | 20 | 10 | 0 | 0 | 3 | 33 | Q2 | 4 | 4 | ||||||||
| Activités d'aide à la réussite | 0 | ||||||||||||||||
| UM-B1-PHARMA-501-M Remédiation disciplinaire en biologie | 0 | 0 | 0 | 0 | 60 | 60 | Q1,Q2 | ||||||||||
| UM-B1-PHARMA-502-M Remédiation disciplinaire en chimie | 0 | 0 | 0 | 0 | 60 | 60 | Q1,Q2 | ||||||||||
| UM-B1-PHARMA-504-M Remédiation disciplinaire en physique | 0 | 0 | 0 | 0 | 50 | 50 | Q1,Q2 | ||||||||||
| Enseignements complémentaires pour l'étudiant qui allège son programme d'études | |||||||||||||||||
| UM-B1-PHARMA-602-M Remises à niveau disciplinaires | 0 | 0 | 0 | 0 | 200 | 200 | Q2 | ||||||||||
| UM-B1-PHARMA-603-M Raisonnement et analyse critique de l'information | 0 | 0 | 0 | 0 | 40 | 40 | Q2 | ||||||||||
| UM-B1-PHARMA-604-M Communication et notions d'éthique et d'empathie | 6 | 4 | 0 | 0 | 0 | 10 | Q2 | ||||||||||
| 60 | |||||||||||||||||
| Bloc 2 | Hours (*) | Term | Credits | Weight. | |||||||||||||
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | ||||||||||||
| Enseignements obligatoires | |||||||||||||||||
| UM-B2-PHARMA-022-M Biochimie métabolique | 40 | 20 | 0 | 0 | 0 | 60 | Q1 | 5 | 5 | ||||||||
UM-B2-PHARMA-003-M Organic Chemistry I  | 22 | 10 | 0 | 0 | 0 | 32 | Q1 | 3 | 3 | ||||||||
| UM-B2-PHARMA-019-M Chimie analytique quantitative | 30 | 60 | 0 | 0 | 0 | 90 | Q1 | 8 | 8 | ||||||||
| UM-B2-PHARMA-006-M Spectroscopy for Pharmaceutical and Biomedical Analysis | 20 | 30 | 0 | 0 | 0 | 50 | Q1 | 4 | 4 | ||||||||
UM-B2-PHARMA-007-M Eléments de physiologie générale  | 18 | 8 | 0 | 0 | 0 | 26 | Q1 | 3 | 3 | ||||||||
| UM-B2-PHARMA-023-M Eléments de splanchnologie | 12 | 0 | 0 | 0 | 0 | 12 | Q1 | 2 | 2 | ||||||||
| UM-B2-PHARMA-014-M Bibliography and IT Tools | 8 | 4 | 0 | 0 | 0 | 12 | Q1 | 2 | 2 | ||||||||
| UM-B2-PHARMA-018-M Statistiques II | 15 | 15 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 | ||||||||
| UM-B2-PHARMA-015-M English for Pharmaceutical Sciences | 48 | 0 | 0 | 0 | 0 | 48 | Q1,Q2 | 4 | 4 | ||||||||
| UM-B2-PHARMA-002-M Molecular Biology | 30 | 46 | 0 | 0 | 0 | 76 | Q2 | 6 | 6 | ||||||||
| UM-B2-PHARMA-004-M Organic Chemistry II | 22 | 57 | 0 | 0 | 0 | 79 | Q2 | 6 | 6 | ||||||||
| UM-B2-PHARMA-008-M Eléments de physiologie spéciale | 30 | 14 | 0 | 0 | 0 | 44 | Q2 | 5 | 5 | ||||||||
| UM-B2-PHARMA-010-M Pharmacognosy I - Introduction to Pharmacognosy | 12 | 15 | 4 | 0 | 0 | 31 | Q2 | 4 | 4 | ||||||||
| UM-B2-PHARMA-011-M Plant Systematics | 12 | 12 | 0 | 0 | 0 | 24 | Q2 | 3 | 3 | ||||||||
| UM-B2-PHARMA-020-M Introduction à la psychologie générale | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 2 | 2 | ||||||||
| Enseignements transitoires 2024-2025 | 0 | ||||||||||||||||
Enseignements transitoires. Veuillez vous référer au document "mesures transitoires" repris sur l'intranet de la faculté | |||||||||||||||||
| UM-B2-PHARMA-001-M Biochimie métabolique (UE transitoire) | 30 | 20 | 0 | 0 | 0 | 50 | Q1 | 5 | 5 | ||||||||
| UM-B2-PHARMA-009-M Eléments de splanchnologie (UE transitoire) | 12 | 0 | 0 | 0 | 0 | 12 | Q1 | 3 | 3 | ||||||||
| Enseignements transitoires 2023-2024 | |||||||||||||||||
| UM-B2-PHARMA-024-M Eléments de physiologie spéciale : systèmes cardiovasculaire et respiratoire (UE transitoire) | 20 | 4 | 0 | 0 | 0 | 24 | Q1 | 1 | 1 | ||||||||
| 61 | |||||||||||||||||
| Bloc 3 | Hours (*) | Term | Credits | Weight. | |||||||||||||
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | ||||||||||||
| Enseignements obligatoires | |||||||||||||||||
| UM-B3-PHARMA-018-M Pharmacochimie: études des médicaments organiques - Partie 1 | 47 | 0 | 0 | 0 | 0 | 47 | Q1 | 6 | 6 | ||||||||
| UM-B3-PHARMA-006-M General Pharmacology | 18 | 10 | 0 | 0 | 0 | 28 | Q1 | 3 | 3 | ||||||||
| UM-B3-PHARMA-007-M Introduction to Cell Pharmacology | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 | ||||||||
| UM-B3-PHARMA-009-M Immunologie | 14 | 0 | 0 | 0 | 0 | 14 | Q1 | 2 | 2 | ||||||||
| UM-B3-PHARMA-015-M English for Pharmaceutical Sciences | 12 | 0 | 6 | 0 | 0 | 18 | Q1 | 2 | 2 | ||||||||
| UM-B3-PHARMA-017-M General Toxicology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-B3-PHARMA-019-M Analyse instrumentale pharmaceutique | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-B3-PHARMA-022-M Analyse pharmaceutique appliquée | 0 | 84 | 0 | 0 | 0 | 84 | Q1 | 3 | 3 | ||||||||
| UM-B3-PHARMA-023-M Principes physico-chimiques appliqués à la technologie pharmaceutique | 24 | 30 | 0 | 0 | 0 | 54 | Q1 | 5 | 5 | ||||||||
| UM-B3-PHARMA-010-M General and medical microbiology | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 5 | 5 | ||||||||
| UM-B3-PHARMA-011-M Elements of Pathology | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 4 | 4 | ||||||||
| UM-B3-PHARMA-012-M Introduction to Pharmacy Training | 0 | 15 | 80 | 0 | 0 | 95 | Q2 | 4 | 4 | ||||||||
| UM-B3-PHARMA-013-M Transdisciplinary Aspects of Pharmaceutical Thematics (CLIL course) | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 | ||||||||
| UM-B3-PHARMA-020-M Etude des médicaments inorganiques | 25 | 0 | 0 | 0 | 0 | 25 | Q2 | 4 | 4 | ||||||||
| UM-B3-PHARMA-021-M Contrôle qualité des matières premières pharmaceutiques | 5 | 80 | 0 | 0 | 0 | 85 | Q2 | 3 | 3 | ||||||||
| UM-B3-PHARMA-024-M Pharmacognosie II: phytochimie et étude des médicaments d'origine végétale | 48 | 0 | 2 | 0 | 0 | 50 | Q2 | 6 | 6 | ||||||||
| 60 | |||||||||||||||||
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term
Please note, the course titles given here are translations of the original titles and are provided in English for information only. In order to know in which language the course will be taught, please refer to the French page. There, the titles provided in French indicate that the course is taught in French and the titles provided in English indicate that the course is taught in English.